With over 20 years of industry experience in the pharmaceutical, biotechnology, diagnostic and nanotechnology fields, I am a seasoned professional who combines scientific knowledge, business acumen, and strategic vision to drive innovation and growth. As the Director of Business Development North America at ZoBio, I am responsible for expanding the company's presence and market share in the region, leveraging its unique capabilities in protein production, biophysical screening, and structure-based drug design. I have successfully secured multiple collaborations and contracts with leading biopharma companies, delivering high-quality and cost-effective solutions for their drug discovery challenges. Previously, I held senior positions at 1859 Inc and Hitgen, where I applied my expertise in DNA encoded libraries, nanotechnology, and mass spectrometry to discover novel small molecule drugs and sell cutting-edge platforms and services. I also co-founded and led a start-up company that developed label-free assays and compound library management tools using high-throughput mass spectrometry. Throughout my career, I have demonstrated a track record of scientific excellence, entrepreneurial spirit, and customer focus. I have been awarded 7 US patents and contributed to the discovery of 2 compounds that advanced into human trials. I have also established and managed successful partnerships and distributorships in Asia, Europe, and North America, generating significant revenue and expanding the global reach of the companies I worked for. My goal is to continue to leverage my skills and experience to create value for the life sciences industry and society.